Clinical Trials Directory

Trials / Completed

CompletedNCT03832439

Probiotic Supplementation on Weight Loss

The Effect of Probiotic Supplementation on Weight Loss, and Its Association With the Gut Microbiome After Bariatric Surgery.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The investigators are trying to better understand how bariatric surgery leads to weight loss, and the role of bacteria that live in the gut in making this happen.

Detailed description

The investigators are interested in seeing how a probiotic, which is a dietary supplement containing large amounts of 'good' bacteria, can influence the make-up of the gut bacterial population and what effect it has on weight loss and loss of fat. Before undergoing weight loss surgery (sleeve gastrectomy or roux-en-y gastric bypass), study participants will be asked to provide a stool sample to assess the make-up of their gut bacterial population. They will also undergo a limited CT scan of the abdomen and DEXA (Xray) to help assess the amount of fat present inside the body. After undergoing weight loss surgery (sleeve gastrectomy or roux-en-y gastric bypass), study participants will be given either a probiotic supplement or dummy pill (placebo) for 3 months, in addition to all usual care that occurs after surgery. The CT scan, DEXA scan and stool sample will be repeated at the end of the 3 month period and analyzed for changes.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbioticLactobacillus rhamnosus GG 10 billion cells and microcrystalline cellulose
DIETARY_SUPPLEMENTmicrocrystalline cellulosePlacebo

Timeline

Start date
2019-01-17
Primary completion
2021-04-28
Completion
2021-04-28
First posted
2019-02-06
Last updated
2022-02-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03832439. Inclusion in this directory is not an endorsement.